Pesquisas alternativas:
carlos rojek » carlos nojek (Expandir a Pesquisa), carlos rojas (Expandir a Pesquisa), carlos roger (Expandir a Pesquisa)
complex than » complex trait (Expandir a Pesquisa)
rsf complex » rnf complex (Expandir a Pesquisa), raf complex (Expandir a Pesquisa), rf complex (Expandir a Pesquisa)
nino carlos » cano carlos (Expandir a Pesquisa), bacino carlos (Expandir a Pesquisa), semino carlos (Expandir a Pesquisa)
than flow » than low (Expandir a Pesquisa), than slow (Expandir a Pesquisa), than from (Expandir a Pesquisa)
nacl nino » nacl nano (Expandir a Pesquisa), nacl kno (Expandir a Pesquisa), nacl mno (Expandir a Pesquisa)
l cooper » _ cooper (Expandir a Pesquisa), i cooper (Expandir a Pesquisa), m cooper (Expandir a Pesquisa)
3 nacl » _ nacl (Expandir a Pesquisa), m nacl (Expandir a Pesquisa), 3.5 nacl (Expandir a Pesquisa)
_ rsf » _ raf (Expandir a Pesquisa), _ rsv (Expandir a Pesquisa), _ rsa (Expandir a Pesquisa)
carlos rojek » carlos nojek (Expandir a Pesquisa), carlos rojas (Expandir a Pesquisa), carlos roger (Expandir a Pesquisa)
complex than » complex trait (Expandir a Pesquisa)
rsf complex » rnf complex (Expandir a Pesquisa), raf complex (Expandir a Pesquisa), rf complex (Expandir a Pesquisa)
nino carlos » cano carlos (Expandir a Pesquisa), bacino carlos (Expandir a Pesquisa), semino carlos (Expandir a Pesquisa)
than flow » than low (Expandir a Pesquisa), than slow (Expandir a Pesquisa), than from (Expandir a Pesquisa)
nacl nino » nacl nano (Expandir a Pesquisa), nacl kno (Expandir a Pesquisa), nacl mno (Expandir a Pesquisa)
l cooper » _ cooper (Expandir a Pesquisa), i cooper (Expandir a Pesquisa), m cooper (Expandir a Pesquisa)
3 nacl » _ nacl (Expandir a Pesquisa), m nacl (Expandir a Pesquisa), 3.5 nacl (Expandir a Pesquisa)
_ rsf » _ raf (Expandir a Pesquisa), _ rsv (Expandir a Pesquisa), _ rsa (Expandir a Pesquisa)
1
“...) being identified more often than von Willebrand disease (73%, n=19/26). All reported having used...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Lovelace, Leslie L., Cooper, Christopher L., Sodetz, James M., Lebioda, Lukasz
Publicado em 2011
“... contain N- and C-terminal modules and a central 40-kDa membrane attack complex perforin (MACPF) domain...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por James, D, Adams, R D, Spears, R, Cooper, G, Lupton, D J, Thompson, J P, Thomas, S H L
Publicado em 2010
“... clinical features reported included agitation or aggression (n=32, 24%, 95% CI 18% to 33%), tachycardia (n...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Collart, Clara, Owens, Nick D. L., Bhaw-Rosun, Leena, Cooper, Brook, De Domenico, Elena, Patrushev, Ilya, Sesay, Abdul K., Smith, James N., Smith, James C., Gilchrist, Michael J.
Publicado em 2014
“... other. Here, we use high-resolution expression profiling to identify three waves of gene activity: a...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Ward, Kim L., Hillman, David R., James, Alan, Bremner, Alexandra P., Simpson, Laila, Cooper, Matthew N., Palmer, Lyle J., Fedson, Annette C., Mukherjee, Sutapa
Publicado em 2013
“... AP; Simpson L; Cooper MN; Palmer LJ; Fedson AC; Mukherjee S. Excessive daytime sleepiness increases...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Cooper, Gregory M., Durham, Emily L., Cray, James J., Siegel, Michael I., Losee, Joseph E., Mooney, Mark P.
Publicado em 2012
“... in vitro and in vivo. METHODS: Cells were derived from the dura mater from wild-type rabbits (WT; n=23...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Ng, David, Johnston, Jennifer J., Teer, Jamie K., Singh, Larry N., Peller, Lindsey C., Wynter, Jamila S., Lewis, Katie L., Cooper, David N., Stenson, Peter D., Mullikin, James C., Biesecker, Leslie G.
Publicado em 2013
“... pathogenic variants associated with dilated cardiomyopathy (n=1), hypertrophic cardiomyopathy (n=2), left...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Cooper, Jennifer N., Columbus, Mindy L., Shields, Kelly J., Asubonteng, Julius, Meyer, Michelle L., Sutton-Tyrrell, Kim, Goodpaster, Bret H., DeLany, James P., Jakicic, John M., Barinas-Mitchell, Emma
Publicado em 2012
“... trial of dietary intervention with (n=45) or without (n=45) physical activity. RESULTS: The achieved...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Ward, Kim L., McArdle, Nigel, James, Alan, Bremner, Alexandra P., Simpson, Laila, Cooper, Matthew N., Palmer, Lyle J., Fedson, Annette C., Mukherjee, Sutapa, Hillman, David R.
Publicado no J Clin Sleep Med (2015)
“...: Ward KL, McArdle N, James A, Bremner AP, Simpson L, Cooper MN, Palmer LJ, Fedson AC, Mukherjee...”Publicado no J Clin Sleep Med (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Cooper, Arthur J. L., Sheu, K.-F. Rex, Burke, James R., Onodera, Osamu, Strittmatter, Warren J., Roses, Allen D., Blass, John P.
Publicado em 1997
“... proteins. Generally, in clinically affected individuals n ≥ 40. Glyceraldehyde 3-phosphate dehydrogenase...”Publicado em 1997
Obter o texto integral
Obter o texto integral
Artigo
11
Por Cooper, Arthur J. L., Sheu, K-F. Rex, Burke, James R., Onodera, Osamu, Strittmatter, Warren J., Roses, Allen D., Blass, John P.
Publicado em 1998
“... give rise to extended stretches of polyglutamines (Q(n)) in the proteins expressed by the affected...”Publicado em 1998
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Bodnar, Lisa M., Catov, Janet M., Zmuda, Joseph M., Cooper, Margaret E., Parrott, Meredith S., Roberts, James M., Marazita, Mary L., Simhan, Hyagriv N.
Publicado em 2010
“... pregnant women with singleton pregnancies who delivered SGA infants (n = 77 white and n = 34 black) or non...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Kang, Soosung, Cooper, Garry, Fernandez Dunne, Sara, Luan, Chi-Hao, Surmeier, D. James, Silverman, Richard B.
Publicado no J Med Chem (2013)
“...Ca(V)1.3 L-type calcium channels (LTCCs) have been a potential target for Parkinson’s disease since...”Publicado no J Med Chem (2013)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Karolemeas, Katerina, de la Rua-Domenech, Ricardo, Cooper, Roderick, Goodchild, Anthony V., Clifton-Hadley, Richard S., Conlan, Andrew J. K., Mitchell, Andrew P., Hewinson, R. Glyn, Donnelly, Christl A., Wood, James L. N., McKinley, Trevelyan J.
Publicado em 2012
“...%). These estimates are more robust than those previously reported in GB due to inclusion of post-mortem data from...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Bragge, Peter, Synnot, Anneliese, Maas, Andrew I., Menon, David K., Cooper, D. James, Rosenfeld, Jeffrey V., Gruen, Russell L.
Publicado no J Neurotrauma (2016)
“..., low risk of bias, n > 100) RCTs, and three-dimensional graphical figures also were used to explore...”Publicado no J Neurotrauma (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Haller, Steven T., Kalra, Philip A., Ritchie, James P., Chrysochou, Tina, Brewster, Pamela, He, Wencan, Yu, Haifeng, Shapiro, Joseph I., Cooper, Christopher J.
Publicado em 2013
“... (survivors, 7.3 ± 0.9 pg/ml, n=48 vs. non-survivors, 6.7 ± 1.0 pg/ml, n=12, p=0.06). The CD40/soluble CD40...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Halai, Reena, Bellows-Peterson, Meghan L, Branchett, Will, Smadbeck, James, Kieslich, Chris A, Croker, Daniel E, Cooper, Matthew A, Morikis, Dimitrios, Woodruff, Trent M, Floudas, Christodoulos A, Monk, Peter N
Publicado no Eur J Pharmacol (2014)
“... and directed in response to invading pathogens or tissue injury. Complement C3a and C5a are key mediators...”Publicado no Eur J Pharmacol (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Hughes, Lorie L., Wang, Molin, Page, David L., Gray, Robert, Solin, Lawrence J., Davidson, Nancy E., Lowen, Mary Ann, Ingle, James N., Recht, Abram, Wood, William C.
Publicado em 2009
“... or smaller who had microscopic margin widths of 3 mm or wider and no residual calcifications on postoperative...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
20
Por Hadler, James L., Danila, Richard N., Cieslak, Paul R., Meek, James I., Schaffner, William, Smith, Kirk E., Cartter, Matthew L., Harrison, Lee H., Vugia, Duc J., Lynfield, Ruth
Publicado no Emerg Infect Dis (2015)
“... attention. The Centers for Disease Control and Prevention funds the 10 EIP sites through cooperative...”Publicado no Emerg Infect Dis (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo